Seguir
David M. Goldenberg
David M. Goldenberg
Founder and Emeritus Chairman of the Board, Immunomedics, Inc.
No hay ninguna dirección de correo electrónico verificada.
Título
Citado por
Citado por
Año
Use of radiolabeled antibodies to carcinoembryonic antigen for the detection and localization of diverse cancers by external photoscanning
DM Goldenberg, F DeLand, E Kim, S Bennett, FJ Primus, JR van Nagell Jr, ...
New England Journal of Medicine 298 (25), 1384-1388, 1978
10631978
Sacituzumab govitecan in metastatic triple-negative breast cancer
A Bardia, SA Hurvitz, SM Tolaney, D Loirat, K Punie, M Oliveira, A Brufsky, ...
New England journal of medicine 384 (16), 1529-1541, 2021
8052021
Sacituzumab govitecan-hziy in refractory metastatic triple-negative breast cancer
A Bardia, IA Mayer, LT Vahdat, SM Tolaney, SJ Isakoff, JR Diamond, ...
New England Journal of Medicine 380 (8), 741-751, 2019
7202019
Immunotherapy of B-cell malignancies using anti-CD22 antibodies
DM Goldenberg
US Patent 6,306,393, 2001
5082001
Targeted therapy of cancer with radiolabeled antibodies
DM Goldenberg
Journal of Nuclear Medicine 43 (5), 693-713, 2002
4612002
A novel method of 18F radiolabeling for PET
WJ McBride, RM Sharkey, H Karacay, CA D'Souza, EA Rossi, ...
Journal of nuclear medicine 50 (6), 991-998, 2009
4502009
Antibody pretargeting advances cancer radioimmunodetection and radioimmunotherapy
DM Goldenberg, RM Sharkey, G Paganelli, J Barbet, JF Chatal
Journal of Clinical Oncology 24 (5), 816, 2006
3972006
Radioimmunodetection of cancer with radioactive antibodies to carcinoembryonic antigen
DM Goldenberg, EE Kim, FH DeLand, S Bennett, FJ Primus
Cancer Research 40 (8_Part_2), 2984-2992, 1980
3901980
Initial clinical trial of epratuzumab (humanized anti-CD22 antibody) for immunotherapy of systemic lupus erythematosus
T Dörner, J Kaufmann, WA Wegener, N Teoh, DM Goldenberg, ...
Arthritis research & therapy 8, 1-11, 2006
3772006
Efficacy and safety of anti-trop-2 antibody drug conjugate sacituzumab govitecan (IMMU-132) in heavily pretreated patients with metastatic triple-negative breast cancer
A Bardia, IA Mayer, JR Diamond, RL Moroose, SJ Isakoff, AN Starodub, ...
Journal of Clinical Oncology 35 (19), 2141, 2017
3682017
Trop-2 is a novel target for solid cancer therapy with sacituzumab govitecan (IMMU-132), an antibody-drug conjugate (ADC)
DM Goldenberg, TM Cardillo, SV Govindan, EA Rossi, RM Sharkey
Oncotarget 6 (26), 22496, 2015
3602015
Targeted therapy of cancer: new prospects for antibodies and immunoconjugates
RM Sharkey, DM Goldenberg
CA: a cancer journal for clinicians 56 (4), 226-243, 2006
3592006
Reducing the renal uptake of radiolabeled antibody fragments and peptides for diagnosis and therapy: present status, future prospects and limitations
TM Behr, DM Goldenberg, W Becker
European journal of nuclear medicine 25, 201-212, 1998
3561998
Anti-CD20 antibodies and fusion proteins thereof and methods of use
H Hansen, Z Qu, DM Goldenberg
US Patent 7,151,164, 2006
3392006
Carcinoembryonic antigen in histopathology: immunoperoxidase staining of conventional tissue sections
DM Goldenberg, RM Sharkey, FJ Primus
Journal of the National Cancer Institute 57 (1), 11-22, 1976
3201976
Multivalent immunoglobulin-based bioactive assemblies
CH Chang, DM Goldenberg, EA Rossi
US Patent 7,527,787, 2009
3152009
Targeting, dosimetry, and radioimmunotherapy of B-cell lymphomas with iodine-131-labeled LL2 monoclonal antibody.
DM Goldenberg, JA Horowitz, RM Sharkey, TC Hall, S Murthy, ...
Journal of clinical oncology 9 (4), 548-564, 1991
3131991
Epratuzumab (humanised anti-CD22 antibody) in primary Sjögren's syndrome: an open-label phase I/II study
SD Steinfeld, L Tant, GR Burmester, NKW Teoh, WA Wegener, ...
Arthritis research & therapy 8, 1-11, 2006
3122006
Phase I/II trial of epratuzumab (humanized anti-CD22 antibody) in indolent non-Hodgkin’s lymphoma
JP Leonard, M Coleman, JC Ketas, A Chadburn, S Ely, RR Furman, ...
Journal of clinical oncology 21 (16), 3051-3059, 2003
3052003
Celecoxib exhibits the greatest potency amongst cyclooxygenase (COX) inhibitors for growth inhibition of COX-2-negative hematopoietic and epithelial cell lines
C Waskewich, RD Blumenthal, H Li, R Stein, DM Goldenberg, J Burton
Cancer research 62 (7), 2029-2033, 2002
3032002
El sistema no puede realizar la operación en estos momentos. Inténtalo de nuevo más tarde.
Artículos 1–20